Validation of an LC-MS/MS method for the quantitative determination of the orexin receptor antagonist almorexant and its four primary metabolites in human plasma
β Scribed by Wagner-Redeker, Winfried; Finsterwald, Isabel; Dingemanse, Jasper
- Book ID
- 122879601
- Publisher
- Elsevier Science
- Year
- 2014
- Tongue
- English
- Weight
- 891 KB
- Volume
- 951-952
- Category
- Article
- ISSN
- 1873-376X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The anticancer drug capecitabine and its metabolites [including the active metabolite 5βfluorouracil (5βFU)] display high pharmacokinetic interβpatient variability. Such variability, which may lead to treatment failure or toxicity, could need drug concentration measurement to individual
A sensitive LC-MS-MS method capable of quantifying terfenadine at levels down to 100 pg ml-1 in human plasma is reported. The method was validated over a linear range from 0.1 to 5.0 ng ml-1 using a liquid-liquid extraction with a deuterium-labelled internal standard. The between-run precision and a